Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Reed

Showing results (251-260 of 283) with videos related to

Pageof 29
Sort By:
Anti-Cancer Drug Design|June 7, 2002
Inhibition of superoxide dismutase by 2-methoxyoestradiol analogues and oestrogen derivatives: structure-activity relationshipsL Wood, M R Leese, B Leblond, et al.
The Journal of Steroid Biochemistry and Molecular Biology|May 3, 2005
The effects of 2-methoxyoestrogen sulphamates on the in vitro and in vivo proliferation of breast cancer cellsT Utsumi, M P Leese, S K Chander, et al.
British Journal of Cancer|August 26, 2004
Pharmacokinetics of the nonsteroidal steroid sulphatase inhibitor 667 COUMATE and its sequestration into red blood cells in ratsC R Ireson, S K Chander, A Purohit, et al.
British Journal of Cancer|November 6, 2008
2-Methoxyoestradiol-3,17-O,O-bis-sulphamate and 2-deoxy-D-glucose in combination: a potential treatment for breast and prostate cancerS L C Tagg, P A Foster, M P Leese, et al.
Anticancer Research|April 13, 2001
Characteristics of cystic breast disease with special regard to breast cancer developmentB Budai, I Számel, Z Sulyok, et al.
Anticancer Research|July 18, 2008
Inhibition of steroid sulphatase activity via the percutaneous route: a new option for breast cancer therapyA Purohit, S K Chander, L W L Woo, et al.
Anticancer Research|April 22, 2011
Effect of tamoxifen or anastrozole on steroid sulfatase activity and serum androgen concentrations in postmenopausal women with breast cancerS J Stanway, C Palmieri, F Z Stanczyk, et al.
The Journal of Endocrinology|November 1, 1978
Plasma hormone levels and the conversion of androstenedione to oestrone in women with endometrial cancer [proceedings]M J Reed, J D Hutton, P M Baxendale, et al.
Annals of the New York Academy of Sciences|January 1, 1986
Androgen and estrogen metabolism in breast cancer patientsV H James, M J Reed, P A Beranek, et al.
Annals of the New York Academy of Sciences|July 29, 1994
Genotoxic chemical carcinogens target inducible genes in vivoJ W Hamilton, J McCaffrey, R M Caron, et al.
Pageof 29

Showing results (251-260 of 283) with videos related to

Sort By:
Pageof 29
Anti-Cancer Drug Design|June 7, 2002
Inhibition of superoxide dismutase by 2-methoxyoestradiol analogues and oestrogen derivatives: structure-activity relationshipsL Wood, M R Leese, B Leblond, et al.
The Journal of Steroid Biochemistry and Molecular Biology|May 3, 2005
The effects of 2-methoxyoestrogen sulphamates on the in vitro and in vivo proliferation of breast cancer cellsT Utsumi, M P Leese, S K Chander, et al.
British Journal of Cancer|August 26, 2004
Pharmacokinetics of the nonsteroidal steroid sulphatase inhibitor 667 COUMATE and its sequestration into red blood cells in ratsC R Ireson, S K Chander, A Purohit, et al.
British Journal of Cancer|November 6, 2008
2-Methoxyoestradiol-3,17-O,O-bis-sulphamate and 2-deoxy-D-glucose in combination: a potential treatment for breast and prostate cancerS L C Tagg, P A Foster, M P Leese, et al.
Anticancer Research|April 13, 2001
Characteristics of cystic breast disease with special regard to breast cancer developmentB Budai, I Számel, Z Sulyok, et al.
Anticancer Research|July 18, 2008
Inhibition of steroid sulphatase activity via the percutaneous route: a new option for breast cancer therapyA Purohit, S K Chander, L W L Woo, et al.
Anticancer Research|April 22, 2011
Effect of tamoxifen or anastrozole on steroid sulfatase activity and serum androgen concentrations in postmenopausal women with breast cancerS J Stanway, C Palmieri, F Z Stanczyk, et al.
The Journal of Endocrinology|November 1, 1978
Plasma hormone levels and the conversion of androstenedione to oestrone in women with endometrial cancer [proceedings]M J Reed, J D Hutton, P M Baxendale, et al.
Annals of the New York Academy of Sciences|January 1, 1986
Androgen and estrogen metabolism in breast cancer patientsV H James, M J Reed, P A Beranek, et al.
Annals of the New York Academy of Sciences|July 29, 1994
Genotoxic chemical carcinogens target inducible genes in vivoJ W Hamilton, J McCaffrey, R M Caron, et al.
Pageof 29